KOSPICosmetics090430

Amorepacific

₩131,100▲ 0.85%2026-11-18 close
Market Cap
₩7.7T
Turnover
₩15.1B
Volume
120K
Shares out.
58.5M
PER
32.4×
PBR
1.4×
EPS
₩4,005
Dividend Yield
0.95%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩1,240 per share · Prices as of the 2026-11-18 close

01

Report overview

Domestic profit recovery and Western expansion; earnings durability is the test

Third-quarter 2026 operating profit rose 25.4% year on year to KRW 115.2 billion, but it has fallen for two straight quarters since the first-quarter peak, so whether Korean margin gains and Western growth can sustain earnings is the key question.

  1. 1

    Third-quarter 2026 operating profit of KRW 115.2 billion grew 25.4% year on year, faster than the 11.1% revenue increase.

  2. 2

    At the core subsidiary Amorepacific, the domestic business lifted operating profit 42% to KRW 84.6 billion in the third quarter of 2026, driving the profit recovery.

  3. 3

    Overseas, the Americas and EMEA led growth while Greater China sales fell 1.5%, continuing the shift away from China dependence.

  4. 4

    Annual operating profit has risen for two consecutive years from 2024 to 2025 after the 2023 low, reaching KRW 335.8 billion in 2025.

  5. 5

    In the third quarter of 2026, non-operating items posted a KRW 44.2 billion loss, so the decline in profit attributable to shareholders was steeper than the operating trend.

02

Business structure

Amorepacific runs a portfolio that spans prestige and basic skincare brands such as Sulwhasoo, HERA and Laneige, dermatology-oriented brands such as Aestura and Illiyoon, and hair care brands such as Mise-en-scene and Ryo.

Within 2024 domestic sales of KRW 2.16 trillion, the luxury division was the largest at KRW 1.24 trillion, followed by the premium division at KRW 439.6 billion and the daily beauty division at KRW 389.2 billion, according to an analysis of the March 2025 annual report by Yakup.

Distribution runs through e-commerce, multi-brand shops such as Olive Young, department stores and duty-free, and in the third quarter of 2026 both e-commerce and multi-brand shop sales grew by double digits.

For the core subsidiary, domestic operations in the third quarter of 2026 produced sales of KRW 620.5 billion, up 11%, and operating profit of KRW 84.6 billion, up 42%.

Overseas operations in the same quarter generated sales of KRW 495.5 billion, up 12%, and operating profit of KRW 48.5 billion, up 14%, with the Americas at KRW 183.2 billion (up 16.9%) and EMEA at KRW 57.9 billion (up 9.9%) both outpacing Greater China at KRW 104.4 billion (down 1.5%).

Dermatology brands Aestura and Illiyoon grew total sales by more than 40%, and an Economy Tribune analysis put their share of total company sales at roughly 20 percent in 2025 and the mid-20 percent range in 2026. A press report said China's share of total sales has fallen from about 30 percent to around 10.6 percent.

Within the wider group, beauty brand companies Innisfree, Etude, Espoir and Amos Professional posted combined third-quarter 2026 sales of KRW 103.2 billion (down 12%) and operating profit of KRW 5.2 billion (down 29%), reflecting channel streamlining. In domestic beauty, the company competes with listed peers including LG H&H and APR.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩1T₩91.9B9.0%
2025Q4₩1.2T₩52.5B4.5%
2026Q1₩1.1T₩126.7B11.2%
2026Q2₩1.2T₩117.3B10.0%
2026Q3₩1.1T₩115.2B10.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩4.1T₩214.2B₩134.5B5.2%2.8%21.4%
2023₩3.7T₩108.2B₩180.1B2.9%3.7%20.8%
2024₩3.9T₩220.5B₩593.2B5.7%11.3%27.4%
2025₩4.3T₩335.8B₩235.7B7.9%4.3%26.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue fell from KRW 4.13 trillion in 2022 to KRW 3.67 trillion in 2023 (down 11.1% year on year), then rose to KRW 3.89 trillion in 2024 (up 5.7%) and KRW 4.25 trillion in 2025 (up 9.5%).

Revenue has grown for two consecutive years from 2024 to 2025, with 2025 the largest year and 2023 the smallest across 2022 to 2025. Operating profit was KRW 214.2 billion in 2022, KRW 108.2 billion in 2023 (down 49.5%), KRW 220.5 billion in 2024 (up 103.8%) and KRW 335.8 billion in 2025 (up 52.3%).

Operating margin moved from 5.2% in 2022 to 2.9% in 2023, 5.7% in 2024 and 7.9% in 2025. In 2025, operating profit grew far faster than revenue, so margin improvement carried more of the gain than sales growth did.

Profit attributable to shareholders was KRW 134.5 billion in 2022 and KRW 180.1 billion in 2023, peaked at KRW 593.2 billion in 2024 (up 229.4%), then fell to KRW 235.7 billion in 2025 (down 60.3%). The drivers of the 2024 surge, including whether any one-off items were involved, require separate confirmation.

Net income including non-controlling interests was KRW 247.3 billion in 2025, down from KRW 601.6 billion in 2024, and the gap with profit attributable to shareholders reflects the non-controlling share.

Quarterly operating profit went from KRW 91.9 billion in the third quarter of 2025 to KRW 52.5 billion in the fourth quarter (down 42.8%), then peaked at KRW 126.7 billion in the first quarter of 2026 (up 141.1%) before falling to KRW 117.3 billion in the second quarter and KRW 115.2 billion in the third, two consecutive quarterly declines.

Bloter attributed the 18% drop in first-quarter 2026 overseas operating profit to higher marketing spending to expand markets. In the third quarter of 2026, non-operating items posted a loss of KRW 44.2 billion, leaving profit attributable to shareholders at KRW 56.2 billion, down 14.8% year on year.

The last four quarters together produced KRW 276.2 billion of profit attributable to shareholders. Operating cash flow rose from KRW 151 billion in 2022 to KRW 583.8 billion in 2025, and the debt-to-equity ratio eased from 27.4% in 2024 to 26.5% in 2025.

05

Industry analysis

Domestic cosmetics exports support the industry backdrop. According to the Ministry of Food and Drug Safety, cumulative Korean cosmetics exports in the first three quarters of 2026 reached USD 11.1 billion, about KRW 14.985 trillion, the highest for the same period on record.

Demand for K-beauty is spreading from China to the United States, Japan and Europe. In China, Greater China sales fell 1.5% to KRW 104.4 billion in the third quarter of 2026, and the company is reshaping its stores around online channels and high-end brands.

The company said Aestura and COSRX each grew more than 100% in Japan, and HERA grew more than 90%, while sales in India rose more than 60%. Mise-en-scene Perfect Serum ranked first in the styling hair serum category during an Amazon event in the United States.

A press report noted that a strengthening of China's domestic beauty industry during the pandemic remains a headwind for foreign brands. In domestic beauty, the company competes with LG H&H and APR, while in contract manufacturing its peers include the listed makers Cosmax and Kolmar Korea.

The company is pursuing a shift from a luxury-centered structure toward dermatology and hair care as new global growth pillars.

06

Outlook

The company's medium-term direction is to raise overseas sales to 70 percent of the total by 2035 and to enter the global top three in premium skincare. With the overseas share reported in the 40 percent range, that target requires a long path.

Western channel expansion is under way: COSRX added about 2,900 new stores in Japan, and its UK TikTok Shop sales rose more than 200%. Aestura entered Boots in the UK and Matas in Northern Europe. In India, Mamonde's market entry and wider distribution continued to expand.

A press report said the company restructured 30-odd of roughly 180 Sulwhasoo stores in China in December 2025, removing low-profit and inefficient outlets. Beauty brand companies such as Innisfree are still streamlining distribution.

A company official said higher digital marketing investment in global markets raised advertising and promotion costs. Hana Securities maintained a target price of KRW 170,000 in a report covered on October 30, 2026, according to press coverage. That target was reported within the last six months.

07

Valuation

PER
32.4×
PBR
1.4×
ROE
5.0%
EPS
₩4,005
BPS
₩95,358
Dividend per share
₩1,240

Market capitalization sits above the book value attributable to shareholders, meaning the stock trades at a premium to net asset value.

Profit attributable to shareholders peaked at KRW 593.2 billion in 2024 and fell to KRW 235.7 billion in 2025, so at the same share price a multiple based on 2025 earnings reads higher than one based on 2024 earnings.

Profit attributable to shareholders over the last four quarters totals KRW 276.2 billion, and quarterly profit has trended lower since the first-quarter 2026 peak.

On an operating basis, profit grew from KRW 214.2 billion in 2022 to KRW 335.8 billion in 2025, and operating margin climbed from 2.9 percent in 2023 to 7.9 percent in 2025, a multi-year recovery in direction. Dividend levels should be read alongside the trend in profit attributable to shareholders.

When comparing multiples with listed peers, the last four quarters should be aligned on the same basis. Comparisons with past multiple bands depend on the share price at each date, so the reference period should be stated explicitly.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Structural improvement in domestic profitability

Domestic operating profit in the third quarter of 2026 rose 42% to KRW 84.6 billion, and the domestic operating margin improved from 10.7% to 13.6%. Reduced discounting and a higher mix of high-margin brands and channels were cited as drivers. Sulwhasoo grew at double-digit rates, and Aestura rose more than 50%.

Geographic diversification into Western markets

Americas sales rose 16.9% to KRW 183.2 billion and EMEA sales rose 9.9% to KRW 57.9 billion in the third quarter of 2026. Combined, the two regions total KRW 241.1 billion, about 2.3 times Greater China sales. Aestura grew more than 80% in Korea, North America and Japan.

Growth expansion in dermatology and hair care

Total sales of dermatology brands such as Aestura and Illiyoon rose more than 40%, and Illiyoon's overseas sales grew six-fold year on year. Hair care sales grew at double-digit rates led by Mise-en-scene, Ryo and Lab.h. The growth base is widening beyond the earlier luxury-centered structure.

09

Bear factors

Continued decline in Greater China sales

Greater China sales fell 1.5% to KRW 104.4 billion in the third quarter of 2026. China, once the main hub, has not yet returned to growth. Its share of sales has fallen to about 10.6 percent, and the Chinese unit turned profitable in the third quarter of 2025, but top-line recovery still needs confirmation.

Overseas marketing costs and margin pressure

Higher advertising and promotion costs weighed on overseas profitability. A company official acknowledged that a sharp increase in digital channel investment in Western markets made a profit decline unavoidable. Overseas operating profit fell 18% to KRW 56.7 billion in the first quarter of 2026.

Quarterly profit decline and non-operating drag

Operating profit has declined for two consecutive quarters, from KRW 126.7 billion at the first-quarter 2026 peak to KRW 117.3 billion and KRW 115.2 billion. Non-operating items posted a KRW 44.2 billion loss in the third quarter of 2026. Profit attributable to shareholders fell 14.8% to KRW 56.2 billion as a result.

10

Risk factors

Delayed recovery in Chinese demand

If China's market recovery stays slow, Greater China sales may keep declining. Reports point to a strengthening of domestic Chinese beauty brands. The company is trimming stores and refocusing on high-end brands and online channels, so whether that reshaping converts into sales recovery remains to be seen.

Profit pressure from marketing investment

Higher digital marketing spending in Western markets is a necessary cost for establishing follow-on brands. If investment efficiency stays low, however, overseas margins may remain under pressure. Overseas operating profit fell 18% in the first quarter of 2026 even as overseas sales rose 6% over the same period.

Reliance on lead brands and weakness in beauty brand companies

A decline in Laneige's North American sales shows the risk of reliance on a lead brand. Combined sales at beauty brand companies including Innisfree, Etude, Espoir and Amos Professional fell 12% and operating profit fell 29%. How quickly growth brands can offset these declines is the next point to watch.

11

What to watch next

  1. Around late January 2027

    Preliminary fourth-quarter and full-year 2026 results. The recovery against the KRW 52.5 billion operating profit of the fourth quarter of 2025, the operating margin trend, and how much overseas marketing cost is reflected are the next points to check.

  2. By late March 2027

    Deadline for the 2026 annual report. The gap between profit attributable to shareholders and net income, the composition of non-operating items, and the China and overseas sales shares will be confirmed in audited figures.

  3. Around late April 2027

    Preliminary first-quarter 2027 results. Whether operating profit recovers to the KRW 126.7 billion first-quarter 2026 peak will indicate the durability of the earnings trend.

12

Overall view

Amorepacific's operating profit reached KRW 335.8 billion in 2025, rising for two consecutive years from 2024 to 2025 after the 2023 low, and third-quarter 2026 operating profit of KRW 115.2 billion was up 25.4% year on year.

Improved domestic profitability, Western growth led by the Americas and EMEA, and the expansion of dermatology and hair care brands support the earnings recovery.

On the other side, operating profit has fallen for two consecutive quarters since the first-quarter 2026 peak, Greater China sales declined, and a non-operating loss widened the drop in profit attributable to shareholders.

Digital marketing investment in Western markets is a cost needed for long-term growth, but it also weighs on near-term profit. Profit attributable to shareholders fell from KRW 593.2 billion in 2024 to KRW 235.7 billion in 2025, so the continuity of the earnings level needs confirmation in upcoming reports.

The next checkpoints are the preliminary fourth-quarter 2026 results, the 2026 annual report, and first-quarter 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. thebk.co.kr
  2. press.todayan.com
  3. mediadale.com
  4. vegannews.co.kr
  5. sidae.com
  6. economytribune.co.kr
  7. shinailbo.co.kr
  8. cncnews.co.kr
  9. lawissue.co.kr
  10. dealsite.co.kr
  11. press9.kr
  12. fntimes.com
  13. dealsite.co.kr
  14. m.yakup.com
  15. apgroup.com
  16. m.news.nate.com
  17. bloter.net
  18. apgroup.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis